Y
Yoko Kurihara
Researcher at University of Tsukuba
Publications - 15
Citations - 137
Yoko Kurihara is an academic researcher from University of Tsukuba. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 8 publications receiving 77 citations.
Papers
More filters
Journal ArticleDOI
Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes
Hiromichi Suzuki,Shigemi Hitomi,Yuji Yaguchi,Kiyoko Tamai,Atsuo Ueda,Kazuhiro Kamata,Yasuharu Tokuda,Hiroshi Koganemaru,Yoko Kurihara,Hiroichi Ishikawa,Hideji Yanagisawa,Katsunori Yanagihara +11 more
TL;DR: During the intervention period, the time of appropriate antimicrobial agents' initiation was significantly earlier than that in the control period (p = 0.001) and most cases were treated with antimicrobialagents with in-vitro susceptibility for causative bacteria the day after the blood culture was obtained.
Journal ArticleDOI
The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2.
Yoko Kurihara,Yoshihiko Kiyasu,Yusaku Akashi,Yuto Takeuchi,Kenji Narahara,Sunao Mori,Tomonori Takeshige,Shigeyuki Notake,Atsuo Ueda,Koji Nakamura,Hiroichi Ishikawa,Hiromichi Suzuki +11 more
TL;DR: In this article, the authors evaluated the diagnostic performance of Quick Chaser® Auto SARS-CoV-2, a novel digital immunochromatographic assay that is expected to have higher sensitivity than conventional antigen tests.
Journal ArticleDOI
Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilis.
Yoko Kurihara,Shigemi Hitomi,Tsuyoshi Oishi,Tsukasa Kondo,Tsugio Ebihara,Yasunori Funayama,Yasushi Kawakami +6 more
TL;DR: Findings indicate that, for P. mirabilis bacteremia, isolation of ESBL-producing strains causes delay of initiating appropriate antimicrobial therapy but may not be associated with mortality.
Journal ArticleDOI
A prospective evaluation of diagnostic performance of a combo rapid antigen test QuickNavi-Flu+COVID19 Ag
Yuto Takeuchi,Yusaku Akashi,Yoshihiko Kiyasu,N. Terada,Yoko Kurihara,D. Kato,T. Miyazawa,Shino Muramatsu,Y. Shiohara,Atsuo Ueda,Shigeyuki Notake,Koji Nakamura,Hiromichi Suzuki +12 more
TL;DR: In this paper , the authors evaluated the clinical performance of a newly developed antigen test QuickNavi-Flu+COVID19 Ag (Denka Co., Ltd., Tokyo, Japan) which can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses at the same time with a single testing device.
Journal ArticleDOI
Adult pneumococcal meningitis presenting with normocellular cerebrospinal fluid: two case reports.
TL;DR: These cases imply that a normal leukocyte count in the cerebrospinal fluid does not exclude the possibility of bacterial meningitis, and Gram staining of cerebroSpinal fluid and immediate administration of antibiotics should be performed in all patients with suspected bacterialMeningitis.